$38.81
00.00%
Pre-Market: 4:52 PM EDT
15 minutes delayed
Comments
Loading...
Protagonist Therapeutics (NASDAQ:PTGX) Stock, Earnings Estimates, EPS, And Revenue
Protagonist Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 13
EPS Estimate
$-0.600
Quarterly Revenue Estimate
$8M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$315M
Analyze the earnings history of Protagonist Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics | -$0.68 | -$0.60 | — | — | $0.00 | $8.00M | — | — | 08/13/2024 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.67 | $2.51 | $3.26 | 29.88% | $0.00 | $120.00M | $254.95M | 112.46% | 05/07/2024 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.69 | -$0.03 | $0.44 | 1566.67% | $0.00 | $40.00M | $60.00M | 50.00% | 02/27/2024 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.64 | -$0.70 | -$0.58 | 17.14% | $0.00 | $10.00M | $0.00 | -100.00% | 11/02/2023 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.84 | -$0.65 | -$0.68 | -4.62% | $859.00K | — | $0.00 | — | 08/03/2023 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.43 | -$0.73 | -$0.67 | 8.22% | $25.72M | $2.00M | $0.00 | -100.00% | 05/04/2023 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.77 | -$0.59 | -$0.69 | -16.95% | $8.62M | $5.00M | $0.00 | -100.00% | 03/15/2023 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.70 | -$0.87 | -$0.64 | 26.44% | $10.29M | — | $0.00 | — | 11/08/2022 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.69 | -$0.93 | -$0.84 | 9.68% | $2.27M | $380.00K | $859.00K | 126.05% | 08/04/2022 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.54 | -$0.63 | -$0.43 | 31.75% | $6.19M | $17.05M | $25.72M | 50.86% | 05/04/2022 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.48 | -$0.78 | -$0.77 | 1.28% | $5.65M | $5.07M | $8.62M | 69.96% | 02/28/2022 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.21 | -$0.67 | -$0.70 | -4.48% | $13.11M | $1.74M | $10.29M | 491.15% | 11/03/2021 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.59 | -$0.51 | -$0.69 | -35.29% | $6.22M | $7.31M | $2.27M | -69.02% | 08/04/2021 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.72 | -$0.57 | -$0.54 | 5.26% | $3.65M | $1.87M | $6.19M | 230.96% | 05/04/2021 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.63 | -$0.48 | -$0.48 | 0.00% | $2.72M | $3.12M | $5.65M | 81.09% | 03/10/2021 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.61 | — | -$0.21 | — | $4.14M | — | $13.11M | — | 11/04/2020 | Get Alert |
| PTGX | Protagonist Therapeutics | -$1.18 | — | -$0.59 | — | -$8.19M | — | $6.22M | — | 08/06/2020 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.58 | -$0.69 | -$0.72 | -4.35% | $1.56M | $1.48M | $3.65M | 146.42% | 05/07/2020 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.57 | -$0.65 | -$0.63 | 3.08% | $2.35M | $3.22M | $2.72M | -15.56% | 03/10/2020 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.38 | — | -$0.61 | — | $6.12M | — | $4.14M | — | 11/06/2019 | Get Alert |
| PTGX | Protagonist Therapeutics | -$0.41 | -$0.28 | -$1.18 | -321.43% | $11.67M | $11.20M | -$8.19M | -173.12% | 08/07/2019 | Get Alert |
Protagonist Therapeutics (PTGX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-07 | $3.26 | $2.51 | 29.9 % |
| Dec 2023 | 2024-02-27 | $0.44 | $-0.03 | 1566.7 % |
| Sep 2023 | 2023-11-02 | $-0.58 | $-0.70 | 17.1 % |
| Jun 2023 | 2023-08-03 | $-0.68 | $-0.65 | -4.62 % |
Protagonist Therapeutics (PTGX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-07 | $254.95M | $120.00M | 112.5 % |
| Dec 2023 | 2024-02-27 | $60.00M | $40.00M | 50.0 % |
| Sep 2023 | 2023-11-02 | $0 | $10.00M | -100.0 % |
| Mar 2023 | 2023-05-04 | $0 | $2.00M | -100.0 % |
FAQ
When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?
Protagonist Therapeutics (PTGX) is scheduled to report earnings on August 13, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
What were the latest earnings per share (EPS) for Protagonist Therapeutics (NASDAQ:PTGX)?
The Actual EPS was $3.26, which beat the estimate of $2.51.
What were Protagonist Therapeutics’s (NASDAQ:PTGX) revenues?
The Actual Revenue was $255M, which beat the estimate of $120M.
Browse earnings estimates, EPS, and revenue on all stocks.